Search
advanced search
search help
ipHandbook Blog
Your source for expert commentary on IP management issues.
Go to the blog
In ipHandbook Forums
See recent topics
About
Editor-in-Chief, Anatole Krattiger
Editorial Board
Concept Foundation
PIPRA
Fiocruz, Brazil
bioDevelopments- Institute
|
CHAPMAN, Audrey R
Audrey Chapman holds the Healey Endowed Chair in Medical Humanities, Law, and Ethics at the University of Connecticut Health Center. She formerly served as the Director of the Science and Human Rights Program at the American Association for the Advancement of Science (AAAS) and as the Co-Director of the AAAS initiative on Science and Intellectual Property in the Public Interest. She is the author, co-author, or editor of sixteen books and numerous articles and reports dealing with ethical, human rights, and intellectual property issues related to health, pharmaceuticals, and genetic developments. She received a Ph.D. in public law and government from Columbia University and graduate degrees in theology and ethics from New York Theological Seminary and Union Theological Seminary. She has worked closely with the United Nations Committee on Economic, Social and Cultural Rights and the UN Special Rapporteur on the Right to Health. She is currently a member of the University of Connecticut Embryonic Stem Cell Oversight Committee, the John Dempsey Hospital Ethics Committee, and the Expert Genomics Advisory Panel of the Connecticut Department of Public Health.
She has worked on a wide range of ethical, human rights, and intellectual property issues related to health and pharmaceuticals.
Abstract
Facilitating Humanitarian Access to Pharmaceutical and Agricultural Innovation
Abstract:
Because certain patenting and licensing strategies can inhibit the development and dissemination of products for developing countries, intellectual property management strategies need to be developed that can help remove some of these obstacles. It is equally important to apply creative patent management strategies that actively promote access to needed products in developing countries. Care must be taken, however, to ensure that patents on research inputs do not discourage or unreasonably increase the cost for product development that targets needs in small or unprofitable markets. The American Association for the Advancement of Science project on Science and Intellectual Property in the Public Interest convened a working group to explore these issues in 2004. This chapter draws upon the expertise of that group to identify licensing strategies that are effective in promoting humanitarian access to health and agricultural product innovations and expanding their use among poor and disadvantaged groups, particularly in low-income countries. The chapter encourages more public sector IP managers to understand and employ strategies that will achieve these goals and seeks to help private sector licensees to understand the rationale behind and potential benefits of such strategies. Indeed, humanitarian licensing strategies should more and more become the norm by contributing to the development and dissemination of essential medicines and agricultural technologies for developing countries.
|